This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Universal Health Services' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Universal Health Services, Inc. ( UHS)

Q4 2011 Earnings Call

February 28, 2012 9:00 am ET

Executives

Steve Filton - SVP and CFO

Alan Miller - CEO

Analysts

A.J. Rice - Susquehanna Financial Group

Adam Feinstein - Barclays Capital

Tom Gallucci - Lazard Capital Markets

Ralph Giacobbe - Credit Suisse First Boston

Justin Lake - UBS Securities

Gary Lieberman - Wells Fargo Securities

Kevin Fishbeck - Bank of America-Merrill Lynch

Darren Lehrich - Deutsche Bank

Christine Arnold - Cowen & Co.

Whit Mayo - Robert W. Baird

Kimberly Purvis - Cross Current Research

Presentation

Operator

At this time, I would like to welcome everyone to the Q4 earnings conference call. (Operator Instructions) Thank you. I would now like to turn the call over to your host Mr. Filton. Sir, you may begin.

Steve Filton

Thank you and good morning. I am Steve Filton. Alan Miller, our CEO, is also joining us this morning. Welcome to this review of Universal Health Services results for the full year and fourth quarter ended December 31, 2011.

During this conference call Alan and I will be using words such as believes, expects, anticipates, estimates, and similar words that represent forecast projections and forward-looking statements. We recommend a careful reading of the section on risk factors and forward-looking statements and risk factors in our Form 10-K for the year ended December 31, 2011. We would like to highlight just a couple of developments and business trends before opening the call up to questions.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASDAQ 4,776.5080 -51.8170 -1.07%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs